- 肺癌全病程管理,让长生存再进一步丨全球肺癌关注月 (0篇回复)
- VC004招募晚期实体瘤患者(NTRK) (0篇回复)
- ICP-723招募晚期实体瘤患者(NTRK) (0篇回复)
- HS301片招募实体瘤患者(NTRK或ROS1或ALK) (0篇回复)
- HG030片招募实体瘤患者(NTRK\ROS1) (0篇回复)
- TQB3558片招募实体瘤患者(NTRK) (0篇回复)
- TL118胶囊招募实体瘤患者(NTRK) (0篇回复)
- 临床招募|XZP-5955招募NTRK或ROS1基因融合的局部晚期或转移性... (0篇回复)
- 临床招募|恩曲替尼招募NTRK1/2/3或ROS1基因融合的实体瘤 (0篇回复)
- 临床招募|谷美替尼招募MET异常的晚期非小细胞肺癌患者 (0篇回复)
页:
[1]